Primary lung carcinoma arising from emphysematous bullae.
To clarify clinical characteristics and biological features of primary lung carcinoma arising from emphysematous bullae (EB), a total of 50 patients (49 males and one female) among all 1478 patients who underwent operation for primary lung carcinoma cases were reviewed; biological features were examined in 31 patients whose resected specimens were available for immunohistochemical staining (IHS). Thirty-one patients (62.0%) had pathologic stage I disease, and 30 cases (60.0%) had poorly differentiated tumor, demonstrating earlier pathologic stages and poorer cell differentiation of lung carcinoma with EB as compared with that without EB. The mean proliferative index (PI) for carcinoma with EB was 64.0%, which was significantly higher than that for carcinoma without EB (47.2%, P = 0.001); no significant difference in Apoptotic index (AI) was demonstrated. Aberrant p53 expression was less frequent in carcinoma with EB (29.0%) than in carcinoma without EB (47.9%, P = 0.043). Five-year survival rates for carcinoma with and that without EB were 50.3 and 46.9%, respectively, showing no significant difference. Multivariate analysis did not demonstrate that association of EB was a significant prognostic factor. In conclusion, although with the poorer cell differentiation and accelerated proliferative activity of lung carcinoma arising from EB, this does not have a significantly different prognosis than primary lung carcinoma not associated with bullae.
Hanaoka
Nobuharu
N
Department of Thoracic Surgery, Faculty of Medicine, Kyoto University, 54 Shogoin Sakyo-ku, Kyoto 606-8507, Japan.
Tanaka
Fumihiro
F
Otake
Yosuke
Y
Yanagihara
Kazuhiro
K
Nakagawa
Tatsuo
T
Kawano
Yozo
Y
Miyahara
Ryo
R
Li
Mio
M
Wada
Hiromi
H
D000368:Aged; D002277:Carcinoma / Q000209:etiology* / Q000503:physiopathology*; D002454:Cell Differentiation; D002455:Cell Division; D002471:Cell Transformation, Neoplastic; D004646:Emphysema / Q000150:complications* / Q000473:pathology*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000209:etiology* / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors